Pharmaceutical Medicine, Biotechnology and European Law

€ 134,99
Lieferbar innert 2 Wochen
Februar 2001



European law has been faced with increasingly complex issues emerging from rapid developments in pharmaceutical medicine and biotechnology. A team of distinguished European legal practitioners and academics reassess the impact of European law on health care and pharmaceutical law. The essays are grouped under four themes: free movement of goods and persons, competition and intellectual property; European drug regulation; biotechnology; and product liability and transnational health care litigation. This important study offers a valuable resource for the pharmaceutical and biotechnology industries, as well as legal academics and practitioners.


Notes on the contributors; Preface; Introduction Richard Goldberg and Julian Lonbay; Part I. Free Movement of Goods and Persons, Competition and Intellectual Property: 1. The free movement of goods I: pharmaceuticals, patents and parallel trade Professor W. R. Cornish; 2. The free movement of goods II: pharmaceuticals, trade marks and parallel imports Belinda Isaac; 3. The free movement of health care professionals in the European Community Julian Lonbay; 4. EC competition law, drugs and intellectual property: recent developments Professor Leigh Hancher; Part II. European Drug Regulation: 5. Data protection and abridged applications for marketing authorisations in the pharmaceutical industry Ian Dodds-Smith; 6. The role of the European Medicines Evaluation Agency (EMEA) in the harmonisation of pharmaceutical regulation Antoine Cuvillier; Part III. Biotechnology: 7. The morality clauses of the Directive on the Legal Protection of Biotechnological Inventions: conflict, compromise, and the patent community Deryck Beyleveld, Professor Roger Brownsword and Margaret Llewelyn; Part IV. Product Liability and Transnational Health Care Litigation: 8. The development risk defence and the European Court of Justice; increased injury costs and the Supplementary Protection Certificate Richard Goldberg; 9. Transnational health care litigation and the Private International Law (Miscellaneous Provisions) Act 1995, Part III Jonathan Harris; Index.


Dr Richard Goldberg is a Solicitor and Lecturer in Law at the Faculty of Law of the University of Birmingham. He is the author of Causation and Risk in the Law of Torts: Scientific Evidence and Medicinal Product Liability, nominated for the SPTL Book Prize in 1999. Dr Julian Lonbay is Senior Lecturer and Director of the Institute of European Law of the University of Birmingham. His publications include Training Lawyers in the European Community, International Professional Practice, Remedies for Breach of EC Law (edited with Biondi), Enhancing the Legal Position of the European Consumer, and Frontiers of Competition Law


'This important study offers a valuable resource for the pharmaceutical and biotechnology industries, legal academics and practitioners alike. It is up-to-date, well researched and presented, and gives an intriguing overview of some of the most pressing issues on the pharmaceutical and biotechnological scene in modern-day Europe.' Maastricht Journal of European and Comparative Law
EAN: 9780521792493
ISBN: 0521792495
Untertitel: New. Sprache: Englisch.
Erscheinungsdatum: Februar 2001
Seitenanzahl: 280 Seiten
Format: gebunden
Es gibt zu diesem Artikel noch keine Bewertungen.Kundenbewertung schreiben